These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

993 related items for PubMed ID: 16202994

  • 1. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V, Bour S, Boucher J, Prévot D, Valet P, Ordener C, Parini A, Carpéné C.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):139-46. PubMed ID: 16202994
    [Abstract] [Full Text] [Related]

  • 2. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
    Carpéné C, Iffiú-Soltesz Z, Bour S, Prévot D, Valet P.
    Pharmacol Res; 2007 Dec 17; 56(6):522-30. PubMed ID: 17977742
    [Abstract] [Full Text] [Related]

  • 3. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S, Iglesias-Osma MC, Marti L, Duro P, Garcia-Barrado MJ, Pastor MF, Prévot D, Visentin V, Valet P, Moratinos J, Carpéné C.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):20-30. PubMed ID: 17056035
    [Abstract] [Full Text] [Related]

  • 4. Tyramine stimulates glucose uptake in insulin-sensitive tissues in vitro and in vivo via its oxidation by amine oxidases.
    Morin N, Visentin V, Calise D, Marti L, Zorzano A, Testar X, Valet P, Fischer Y, Carpéné C.
    J Pharmacol Exp Ther; 2002 Dec 15; 303(3):1238-47. PubMed ID: 12438548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
    Carpéné C, Abello V, Iffiú-Soltész Z, Mercier N, Fève B, Valet P.
    Pharmacol Res; 2008 Jun 15; 57(6):426-34. PubMed ID: 18539478
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
    Morin N, Lizcano JM, Fontana E, Marti L, Smih F, Rouet P, Prévot D, Zorzano A, Unzeta M, Carpéné C.
    J Pharmacol Exp Ther; 2001 May 15; 297(2):563-72. PubMed ID: 11303044
    [Abstract] [Full Text] [Related]

  • 10. Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidases.
    Visentin V, Morin N, Fontana E, Prévot D, Boucher J, Castan I, Valet P, Grujic D, Carpéné C.
    J Pharmacol Exp Ther; 2001 Oct 15; 299(1):96-104. PubMed ID: 11561068
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
    Prévot D, Soltesz Z, Abello V, Wanecq E, Valet P, Unzeta M, Carpéné C.
    Pharmacol Res; 2007 Jul 15; 56(1):70-9. PubMed ID: 17548204
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alteration of amine oxidase activity in the adipose tissue of obese subjects.
    Visentin V, Prévot D, De Saint Front VD, Morin-Cussac N, Thalamas C, Galitzky J, Valet P, Zorzano A, Carpéné C.
    Obes Res; 2004 Mar 15; 12(3):547-55. PubMed ID: 15044673
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
    Kinemuchi H, Sugimoto H, Obata T, Satoh N, Ueda S.
    Neurotoxicology; 2004 Jan 15; 25(1-2):325-35. PubMed ID: 14697907
    [Abstract] [Full Text] [Related]

  • 17. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
    Carpéné C, Bizou M, Tréguer K, Hasnaoui M, Grès S.
    J Physiol Biochem; 2015 Sep 15; 71(3):487-96. PubMed ID: 25572340
    [Abstract] [Full Text] [Related]

  • 18. Absence of tissue-bound semicarbazide-sensitive amine oxidase activity in carp tissues.
    Takahashi K, Kakuta I, Sugimoto H, Obata T, Oreland L, Kinemuchi H.
    Life Sci; 2007 Feb 27; 80(12):1094-9. PubMed ID: 17215008
    [Abstract] [Full Text] [Related]

  • 19. Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells.
    Fontana E, Boucher J, Marti L, Lizcano JM, Testar X, Zorzano A, Carpéné C.
    Biochem J; 2001 Jun 15; 356(Pt 3):769-77. PubMed ID: 11389684
    [Abstract] [Full Text] [Related]

  • 20. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.
    Bour S, Daviaud D, Gres S, Lefort C, Prévot D, Zorzano A, Wabitsch M, Saulnier-Blache JS, Valet P, Carpéné C.
    Biochimie; 2007 Aug 15; 89(8):916-25. PubMed ID: 17400359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.